Changchun Institute of Biological Products Co., Ltd.
Establishment time : 1958
website : http://www.cibp.cncn.com/
Main Product : vaccines, biological products
Company Profile
Changchun Institute of Biological Products Co., Ltd. was established in 1958 and has since become a key player in the field of vaccines and biological products. With a large market share in China and a growing presence in international markets, the company is known for its innovative products and dedication to public health.
Wuhan Institute of Biological Products Co., Ltd.
Establishment time : 1967
website : http://www.whbp.com.cn/
Main Product : Vaccines, biological products
Company Profile
Wuhan Institute of Biological Products Co., Ltd. is a leading biopharmaceutical company specializing in the research, development, and production of vaccines and biological products. Established in 1967, the company has a strong presence in both domestic and international markets, offering a wide range of high-quality products to meet the healthcare needs of people worldwide. With a large company size and a competitive market position, Wuhan Institute of Biological Products Co., Ltd. continues to strive for excellence in the field of biopharmaceuticals.
Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.
Establishment time : 1998
website : www.tianyuanpharm.com
Main Product : Heparin Sodium, Chondroitin Sulfate, Hyaluronic Acid, etc.
Company Profile
Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. is a leading manufacturer and supplier of bio-pharmaceutical products, including heparin sodium, chondroitin sulfate, and hyaluronic acid. Established in 1998, the company has grown to become a key player in the pharmaceutical industry, serving both domestic and international markets. With a strong competitive position, Tianyuan Bio-Pharmaceutical is committed to providing high-quality products to meet the needs of customers worldwide.
Chengdu Institute of Biological Products Co., Ltd.
Establishment time : 1967
website : http://www.cibp.cicp.ac.cn/
Main Product : Vaccines, biological products
Company Profile
Chengdu Institute of Biological Products Co., Ltd. is a renowned company specializing in the research, development, and production of vaccines and biological products. Established in 1967, the company has grown to become a key player in the industry, serving both domestic and international markets. With a large company size and a strong competitive position, Chengdu Institute of Biological Products Co., Ltd. continues to innovate and provide high-quality products to meet the needs of its customers.
Changchun Zhuoyi Biological Co., Ltd
Company Profile
Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.
Shenzhen Kangtai Biological Products Co., Ltd.
Establishment time : 1992
website : www.kangtai-bio.com
Main Product : Vaccines, blood products, and diagnostic reagents
Company Profile
Shenzhen Kangtai Biological Products Co., Ltd. was founded in 1992 and has since become a prominent player in the biopharmaceutical industry. With a wide range of products including vaccines, blood products, and diagnostic reagents, the company serves markets in China, Asia, Africa, and South America. With a large workforce of over 3,000 employees, Kangtai is known for its commitment to quality and innovation, making it a leading competitor in the global market. Visit their website at www.kangtai-bio.com for more information.
Hualan Biological Engineering Inc.
Establishment time : Hualan Biological Engineering Inc. was founded in 1998.
website :
Main Product : Hualan Biological Engineering Inc. is a large company with a strong presence in both the Chinese and international markets.
Company Profile
Hualan Biological Engineering Inc. continues to expand its product portfolio and reach new markets around the world.
Beijing Tiantan Biological Products Co., Ltd.
Establishment time : Beijing Tiantan Biological Products Co., Ltd. was founded in 1992.
website :
Main Product : With a large company size, Beijing Tiantan is a major player in the healthcare industry.
Company Profile
Beijing Tiantan Biological Products Co., Ltd. is committed to improving public health through innovative vaccine solutions.
July 26, 2024
